Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025
Rhea-AI Summary
Stereotaxis (NYSE: STXS) will report its third quarter 2025 financial results on Tuesday, November 11, 2025 after the U.S. market close.
The company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) the same day to discuss results and corporate developments. Participants may dial 800-715-9871 (US/Canada) or 646-307-1963 (international) using pass code 4402192. A live and replay webcast will be available via the company’s investor relations website, and a phone replay will be available for one month beginning about four hours after the call.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, STXS declined 1.61%, reflecting a mild negative market reaction. This price movement removed approximately $5M from the company's valuation, bringing the market cap to $278M at that time.
Data tracked by StockTitan Argus on the day of publication.
ST. LOUIS, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2025 third quarter on Tuesday, November 11, 2025 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the Company’s results and corporate developments.
| What: | Stereotaxis third quarter 2025 financial results conference call |
| When: | Tuesday, November 11, 2025, at 4:30 p.m. ET (1:30 p.m. PT) |
| Dial In Number: | To access the live call, dial 800-715-9871 (US and Canada) or 646-307-1963 (International) and give the participant pass code 4402192. |
| Webcast: | To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/. |
| Call Replay: | A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here. |
About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 150,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.
Investor Contacts:
David L. Fischel
Chairman and Chief Executive Officer
Kimberly Peery
Chief Financial Officer
314-678-6100
Investors@Stereotaxis.com
FAQ
When will Stereotaxis (STXS) report Q3 2025 results?
What time is the Stereotaxis (STXS) earnings call on November 11, 2025?
How can I join the Stereotaxis (STXS) Q3 2025 conference call?
Where can investors watch the Stereotaxis (STXS) webcast and replay?
Will a phone replay of the Stereotaxis (STXS) Q3 2025 call be available?
Who are the investor contacts for Stereotaxis (STXS)?
